Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment

Muscle Nerve. 2013 Dec;48(6):992-3. doi: 10.1002/mus.24063. Epub 2013 Oct 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antigens, CD19 / metabolism
  • B-Lymphocytes / pathology*
  • Cell Count
  • Fatty Acids, Monounsaturated / immunology
  • Female
  • Humans
  • Immunologic Deficiency Syndromes / etiology*
  • Immunologic Factors / adverse effects*
  • Middle Aged
  • Myasthenia Gravis / drug therapy
  • Myasthenia Gravis / immunology
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD19
  • Fatty Acids, Monounsaturated
  • Immunologic Factors
  • musk
  • Rituximab